Summary
When a neurotransmitter substance is released into a synaptic cleft it acts upon subsynaptic receptors to induce a response of the target cell and also interacts with systems which act to remove the substance. At no time is there an equilibrium, and it is inappropriate to apply equilibrium kinetics to predict the consequences of modifying the system, e.g. by blocking receptors. A mathematical model predicts that the subsynaptic response to each package or “quantum” of transmitter may be insensitive to competitive receptor blockade, or to quite large changes in receptor density, provided the density of receptors is normally enough for efficient capture of transmitter. This prediction is borne out by experimental data from the voltage-clamped mouse neuromuscular junction; it requires blockade or removal of about 80% of receptors (90% after poisoning of acetylcholinesterase) to reduce the miniature end-plate current, i.e. the action of a quantum if nerve-released acetylcholine (ACh), by 50%. On the other hand, drugs that interfere with receptor function without preventing ACh binding to receptors can be just as (or more) effective in blocking nerve-applied as in blocking exogenously applied transmitter substances. At the neuromuscular junction this is seen with receptor desensitization, and “non-specific” agents such as local and general anaesthetics. We conclude that care must be taken in extrapolating from data re receptor number and/or occupancy by blocking drugs to consequences in terms of synaptic function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, P.R.: A model for the procaine end-plate current. J. Physiol. (Lond.) 246, 61–63 (1975).
Colquhoun, D., Dreyer, F., Sheridan, E.: The actions of tubocurarine at the frog neuromuscular junction. J. Physiol. (Lond.) 266, 361–395 (1979).
Dreyer, F., Peper, K., Sterz. R.: Determination of dose response curves by quantitations iontophoresis at the frog neuromuscular junction. J. Physiol. (Lond.) 281, 421–444 (1978).
Elmgvist, D., Hofmann, W. W, Kugelberg, j, Quastel D. MI: An electrophysiological investigation of neuromuscular transmission in myasthenia gravis. J. Physiol. (Lond.) 174, 417–434 (1964).
Fambrough, D. M., Hartzell, H. C.: Acetylcholine receptors: number and distribution at neuromuscular junctions in rat diaphragm. Science (N.Y.) 176, 189–191 (1972).
Feltz, A., Trautmann, A.: Desensitization at the frog neuromuscular junction: a biphasic process. J. Physiol. (Lond.) 322, 257–272 (1982).
Fertuck, H. C., Salpeter, M. M.: Localization of acetylcholine receptor by 1zsI labelled a-bungarotoxin binding at mouse motor endplate. Proc. Natl. Acad. Sci., U.S.A. 71, 1376–1378 (1974).
Fertuck, H. C., Salpeter, M. M.: Quantitation of junctional and extra-junctional acetylcholine receptors by electron microscope autoradiography after 121-a-bungarotoxin binding at mouse neuromuscular junctions. J. Cell. Biol. 69, 144–158 (1976).
Gage, P. W, McBurney, R. N, Schneider, G. T.: Effects of some aliphatic alcohols on the conductance change caused by a quantum of acetylcholine at the toad endplate. J. Physiol. (Lond.) 244, 409–429 (1975).
Hartzell H. C., Kugler, S. W, Yoshikami, D.: Post-synaptic potentiation: interaction between quanta of acetylcholine at the skeletal neuromuscular synapse. J. Physiol. (Lond.) 152, 309–324 (1975).
Katz B., Miledi, R.: The binding of acetylcholine in receptors and its removal from the synaptic cleft. J. Physiol. (Lond.) 231, 549–574 (1973).
Katz, B., Thesleff S.: A study of the desensitization produced by acetylcholine at the motor end-plate. J. Physiol. (Lond.) 138, 60–80 (1957).
Pennefather, P., Quastel, D. M.J.: The effects of myasthenic IgG on miniature end-plate currents in mouse diaphragm. Life Sci. 27, 2047–2054 (1980 a).
Pennefather, P., Quastel, D. M.J.: Actions of Anesthetics on the function of nicotinic acetylcholine receptors. In: Progress in Anesthesiology, Vol. 2: Molecular Mechanisms of Anesthetics (Fink, B. R., ed.), pp. 157–168. New York: Raven Press. 1980 b.
Pennefather, P., Quastel, D. M.J.: Relation between subsynaptic receptor blockade and response to quantal transmitter at the mouse neuromuscular junction. J. Gen. Physiol. 78, 313–344 (1981).
Pennefather, P., Quastel, D. M.J.: Modifications of dose-response curves by effector blockade and uncompetitive antagonism. Molec. Pharmacol. 22, 369–380 (1982).
Quastel, D. M.J., Linder, T. M.: Pre- and post-synaptic actions of central depressants at the mammalian neuromuscular junction. In: Progress in Anesthesiology, Vol. 1: Molecular Mechanisms of Anaesthesia (Fink, B. R., ed.), pp. 157–168. New York: Raven Press. 1975.
Richter, J., Landau, E. M., Cohen, S.: The action of volatile anesthetics and convulsants on synaptic transmission: A unified concept. Molec. Pharmacol. 13, 548–559 (1977 a).
Richter, J., Landau, E. M., Cohen, S.: Effect of fluorinated ethers on channel conductance in a cholinergic synapse. Isr. J. Med. Sci. 13, 533–534 (1977 b).
Wathey, J. C., Nass, W. M., Lester, H. A.: Numerical reconstruction of the quantal event at nicotinic synapses. Biophys. J. 27, 145–164 (1979).
Authors’ address: Prof. Dr. D. Quastel, Department of Pharmacology, The University of British Columbia, 2176 Health Sciences Mall, Vancouver, B.C., Canada V6T 1W5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Wien
About this paper
Cite this paper
Quastel, D.M.J., Pennefather, P. (1983). Receptor Blockade and Synaptic Function. In: Goldstein, M., Jellinger, K., Riederer, P. (eds) Basic Aspects of Receptor Biochemistry. Journal of Neural Transmission, vol 18. Springer, Vienna. https://doi.org/10.1007/978-3-7091-4408-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-4408-4_7
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-4410-7
Online ISBN: 978-3-7091-4408-4
eBook Packages: Springer Book Archive